A patient with type 2 diabetes presents with symptoms of peripheral neuropathy and poor glycemic control, as indicated by an HbA1c of 8.2%. The healthcare team is considering adding a GLP-1 receptor agonist to the patient's treatment plan. What is the primary nursing consideration when initiating this medication to ensure patient safety and effectiveness?

C) Assess the patient's injection technique and rotate injection sites to prevent lipodystrophy.

A) Monitor for signs of acute renal failure and adjust dosage accordingly.

B) Educate the patient on recognizing signs of hypoglycemia and how to manage them.

C) Assess the patient's injection technique and rotate injection sites to prevent lipodystrophy.

D) Instruct the patient to take the medication with meals to enhance absorption.

A patient with diabetes mellitus presents with numbness in the feet, blurring vision, and laboratory findings indicating poor glycemic control and early nephropathy. Which nursing intervention is most appropriate to prioritize in the management plan to address the patient's current symptoms and prevent further complications?

A) Educate the patient on the importance of strict blood glucose monitoring and adherence to a prescribed diet.

B) Refer the patient to a podiatrist for regular foot care and assessment to prevent ulcer formation.

C) Initiate referral to a dietitian for a personalized meal planning to improve lipid profile management.

D) Schedule frequent follow-up appointments for regular monitoring of renal function and blood pressure.

A patient with type 2 diabetes is on GLP-1 receptor agonist therapy and is experiencing slight improvement in glycemic control and weight loss. Despite these improvements, the patient reports persistent blurred vision, and an ophthalmology report confirms mild non-proliferative diabetic retinopathy. Given the current clinical findings, what should be the priority nursing intervention to address the patient's vision concerns?

A) Educate the patient on the importance of regular ophthalmic examinations and maintaining optimal blood sugar control.

B) Suggest the patient increase daily walks to further enhance weight loss and glycemic control.

C) Recommend an immediate switch to insulin therapy to rapidly lower blood glucose levels.

D) Advise the patient to temporarily stop GLP-1 receptor agonist therapy until vision improves.

A patient with type 2 diabetes has been on GLP-1 receptor agonist therapy and lifestyle modifications, showing slight improvements in weight, blood pressure, and HbA1c levels. However, the patient reports persistent blurred vision, and an ophthalmology report confirms mild non-proliferative diabetic retinopathy. What is the most appropriate nursing intervention to prioritize in managing this patient's condition?

A) Educate the patient on the importance of rigorous glycemic control to prevent the progression of retinopathy.

B) Advise the patient to reduce physical activity to prevent further deterioration of vision.

C) Recommend increasing the dosage of GLP-1 receptor agonist to accelerate glycemic control.

D) Suggest discontinuing GLP-1 receptor agonist therapy due to its potential side effects on vision.

A patient with a history of diabetes and hypertension is experiencing episodes of dizziness and increased nocturia after starting an ACE inhibitor. The patient's blood pressure is 132/80 mmHg seated and drops to 110/70 mmHg upon standing. Laboratory results show a slight decrease in eGFR to 55 mL/min/1.73 m² and an increase in urine albumin-to-creatinine ratio to 35 mg/g. Which nursing intervention is most appropriate to address the patient's orthostatic hypotension while managing their kidney function?

B) Encourage the patient to rise slowly from sitting to standing to reduce dizziness.

A) Increase the patient's sodium intake to improve blood pressure stability.

B) Encourage the patient to rise slowly from sitting to standing to reduce dizziness.

C) Discontinue the ACE inhibitor and switch to a different antihypertensive medication.

D) Advise the patient to restrict fluid intake to prevent further kidney damage.

A patient with diabetic nephropathy and newly diagnosed orthostatic hypotension is being managed with an ACE inhibitor. Which nursing intervention is most appropriate to address the patient's current symptoms and prevent further complications?

A) Encourage the patient to increase fluid intake and monitor blood pressure regularly.

B) Advise the patient to reduce sodium intake strictly and avoid all physical activity.

C) Suggest the patient to lie down immediately after taking medications to avoid dizziness.

D) Recommend the patient take over-the-counter diuretics to manage nocturia.

A patient with a history of chronic kidney disease and recent medication adjustment returns with bilateral pitting edema, increased weight, and a decline in renal function. Which nursing intervention is most appropriate to address the current fluid retention and prevent further renal deterioration?

B) Initiate a low-sodium diet and monitor daily weight

A) Encourage increased fluid intake to promote kidney filtration

B) Initiate a low-sodium diet and monitor daily weight

C) Discontinue all antihypertensive medications to reduce renal strain

D) Advise complete bed rest to minimize edema

A patient with worsening nephropathy and signs of fluid retention has been prescribed a diuretic. Which nursing intervention is most crucial to implement in the care plan to prevent further complications?

C) Monitor the patient's weight daily and report any sudden increases.

A) Encourage the patient to increase fluid intake to ensure adequate hydration.

B) Instruct the patient to avoid potassium-rich foods to prevent hyperkalemia.

C) Monitor the patient's weight daily and report any sudden increases.

D) Advise the patient to limit protein intake to reduce kidney workload.

A patient who recently started a diuretic presents with new-onset palpitations and mild shortness of breath. Considering the patient's condition, what is the most appropriate nursing action?

B) Advise the patient to consume potassium-rich foods to address possible hypokalemia.

A) Encourage the patient to increase fluid intake to counteract dehydration.

B) Advise the patient to consume potassium-rich foods to address possible hypokalemia.

C) Instruct the patient to reduce physical activity until a cardiology evaluation is completed.

D) Recommend the patient to stop the diuretic until symptoms resolve.

A patient who recently started on a diuretic reports new symptoms of palpitations and mild shortness of breath. Vital signs show a slightly elevated heart rate, and laboratory results reveal stable renal function but unchanged urine albumin-to-creatinine ratio. Which nursing action is most appropriate based on these findings?

B) Assess the patient's electrolyte levels to determine if an imbalance is causing the symptoms.

A) Increase the dosage of the diuretic to manage fluid retention more effectively.

B) Assess the patient's electrolyte levels to determine if an imbalance is causing the symptoms.

C) Advise the patient to increase fluid intake to counteract dehydration.

D) Suggest the patient discontinue the diuretic until symptoms resolve.

Type 2 diabetes - Nursing Case Study

Pathophysiology

• Primary mechanism: Insulin resistance – Body cells, particularly muscle, fat, and liver cells, become less responsive to insulin, reducing glucose uptake and storage, leading to elevated blood glucose levels.

• Secondary mechanism: Beta-cell dysfunction – Over time, pancreatic beta cells become unable to compensate for increased insulin demand, leading to impaired insulin secretion and exacerbating hyperglycemia.

• Key complication: Hyperglycemia-induced damage – Chronic high blood glucose levels can lead to vascular damage, contributing to complications like neuropathy, retinopathy, and nephropathy, which are critical concerns in diabetes management.

Patient Profile

Demographics:

52-year-old male, office manager

History:

• Key past medical history: Diagnosed with Type 2 diabetes 8 years ago, hypertension, hyperlipidemia

• Current medications: Metformin, Lisinopril, Atorvastatin, Glimepiride

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increasing fatigue and intermittent blurred vision

• Key symptoms: Numbness in feet, frequent urination, increased thirst, occasional dizziness

• Vital signs: Blood pressure 145/90 mmHg, heart rate 88 bpm, respiratory rate 18 breaths per minute, temperature 98.6°F, blood glucose level 210 mg/dL

Section 1

During a follow-up visit, the patient reports that his symptoms have persisted, and he is particularly concerned about the increasing numbness in his feet and the blurring of his vision. A comprehensive neurological assessment reveals decreased sensation in the patient's feet, particularly in the distal regions, which is consistent with peripheral neuropathy. The patient also mentions having difficulty reading fine print and needing brighter lighting to see clearly, prompting a referral to an ophthalmologist for further evaluation of potential diabetic retinopathy.

Recent laboratory results show an HbA1c of 8.2%, indicating poor glycemic control over the past three months. Renal function tests reveal a slight increase in serum creatinine levels at 1.3 mg/dL, and urine microalbumin levels are elevated at 45 mg/L, suggesting early signs of nephropathy. The patient's lipid profile shows a total cholesterol level of 230 mg/dL, LDL at 140 mg/dL, HDL at 38 mg/dL, and triglycerides at 180 mg/dL, indicating suboptimal lipid management despite ongoing atorvastatin therapy.

Given these findings, the clinical team discusses potential adjustments to the patient's management plan. The endocrinologist considers intensifying the patient's diabetes regimen by introducing a GLP-1 receptor agonist to improve glycemic control and potentially aid in weight management. Additionally, counseling on lifestyle modifications, including dietary changes and increased physical activity, is reinforced to address the patient's overall cardiovascular risk profile. These interventions aim to prevent progression of complications and improve the patient's quality of life. However, the team remains vigilant for any new complications that might arise due to the complex interplay of the patient's existing conditions.

Section 2

Several weeks after adjusting the management plan, the patient returns for a follow-up appointment. This visit focuses on evaluating the response to the newly introduced GLP-1 receptor agonist therapy and lifestyle modifications. The patient reports feeling slightly more energetic and has noticed a modest weight loss of approximately 3 pounds. He also mentions adhering more closely to the recommended dietary changes and has increased his physical activity by taking daily walks.

Vital signs are measured and reveal a blood pressure of 138/84 mmHg, slightly improved from previous readings but still indicative of potential hypertension. His heart rate is 78 beats per minute, and his body mass index (BMI) has decreased to 29.5 kg/m². A repeat HbA1c test shows a slight improvement at 7.9%, suggesting some progress in glycemic control, although it remains above the target level. The patient also undergoes a repeat lipid profile, showing a total cholesterol level of 220 mg/dL, LDL at 130 mg/dL, HDL at 40 mg/dL, and triglycerides at 170 mg/dL, indicating marginal improvement but still necessitating ongoing management.

Despite these improvements, the patient expresses continued concern about his vision, reporting that the blurring persists. The recent ophthalmology report confirms the presence of mild non-proliferative diabetic retinopathy, prompting continued close monitoring and emphasizing the importance of optimal glycemic control to prevent further progression. The clinical team encourages the patient to maintain his current efforts and considers the addition of an ACE inhibitor to address early nephropathy signs and further protect renal function. As the team evaluates these results, they remain attentive to new developments and potential complications that may arise as they guide the patient towards better health outcomes.

Section 3

Several weeks later, the patient presents for another follow-up visit, reporting intermittent episodes of dizziness and an increased frequency of nocturia. These symptoms raise concerns about potential orthostatic hypotension or advancing nephropathy. Upon physical examination, the patient's blood pressure is measured at 132/80 mmHg while seated, but drops to 110/70 mmHg upon standing, confirming a postural drop and suggesting orthostatic hypotension as a possible side effect of the recently added ACE inhibitor.

New laboratory results reveal that the patient's estimated glomerular filtration rate (eGFR) has decreased slightly to 55 mL/min/1.73 m², and his urine albumin-to-creatinine ratio has increased to 35 mg/g, indicating a progression of diabetic nephropathy. The team is prompted to re-evaluate the patient's medication regimen, considering the need for a delicate balance between managing blood pressure and protecting kidney function.

In light of these findings, the clinical team decides to adjust the dosage of the ACE inhibitor while reinforcing the importance of hydration and monitoring orthostatic symptoms. They also emphasize the need for continued lifestyle modifications, including dietary adjustments to manage sodium intake and maintain blood pressure control. The patient is advised to report any further episodes of dizziness or changes in urinary habits promptly. These developments necessitate close monitoring and a collaborative approach to prevent further complications, ensuring the patient's journey towards improved health remains on track.

Section 4

Several weeks after the medication adjustment, the patient returns for a follow-up appointment, reporting that the episodes of dizziness have lessened, but he has now noticed swelling in his ankles and feet. During the physical examination, the nurse observes bilateral pitting edema in the lower extremities. Vital signs are taken and show a blood pressure of 128/78 mmHg while seated and 115/72 mmHg upon standing, indicating a slight improvement in orthostatic tolerance. The patient's weight has increased by 2 kg since the last visit, suggesting fluid retention.

New laboratory results offer further insight into the patient's condition. His serum creatinine level has risen to 1.6 mg/dL, and the eGFR has decreased further to 50 mL/min/1.73 m², underscoring a decline in renal function. The urine albumin-to-creatinine ratio now stands at 45 mg/g, indicating worsening nephropathy. The clinical team is concerned about the potential for heart failure, given the fluid retention and renal function decline, and they recognize the need to reassess the patient's treatment plan.

To address these new complications, the team discusses the introduction of a diuretic to manage fluid overload while continuing to carefully monitor kidney function. They emphasize the importance of strict adherence to fluid and sodium restrictions to prevent exacerbating the patient's condition. The patient is instructed to monitor his weight daily and to promptly report any further swelling, shortness of breath, or changes in urinary patterns. These steps are vital to managing the delicate balance between heart and kidney health, and the team plans for more frequent follow-ups to closely monitor the patient's progress.

Section 5

Two weeks after the introduction of the diuretic and implementation of fluid and sodium restrictions, the patient returns for a scheduled follow-up. During this visit, the nurse notes that the patient reports feeling more energetic and states that the swelling in his ankles and feet has decreased significantly. However, he mentions experiencing occasional palpitations and mild shortness of breath when climbing stairs, which are new symptoms since the last appointment.

The physical examination reveals a reduction in the severity of pitting edema, now only trace in the lower extremities. The patient's weight has decreased by 1.5 kg since initiating the diuretic, suggesting effective fluid management. Vital signs indicate a blood pressure of 126/80 mmHg while seated and 112/70 mmHg upon standing, showing continued improvement in orthostatic tolerance. However, the heart rate is slightly elevated at 98 beats per minute, which may correlate with the reported palpitations.

New laboratory results show a stable serum creatinine level of 1.5 mg/dL and an eGFR of 55 mL/min/1.73 m², suggesting a slight improvement in renal function. The urine albumin-to-creatinine ratio remains unchanged at 45 mg/g. Given these findings, the clinical team considers whether the palpitations and breathlessness could indicate an electrolyte imbalance, potentially a side effect of the diuretic therapy. They decide to monitor electrolyte levels closely and reassess the diuretic dosage if necessary. The patient is advised to continue monitoring his symptoms and to maintain his current dietary restrictions. The team plans for a follow-up visit in one week to evaluate the patient's response to these interventions and to ensure no further complications arise.